Dartmouth researchers have discovered that immune cells called macrophages play opposing roles in cancer, with some fighting tumors, while others help them grow. A study published in Nature Immunology points to a more precise approach to cancer treatment by selectively blocking the cells that suppress the body’s natural defenses, using a drug already approved by the FDA.
Dartmouth’s Geisel School of Medicine and Dartmouth Health both rose in the recently released 2025 Blue Ridge Institute for Medical Research (BRIMR) rankings, which assesses National Institutes of Health (NIH) funding across 145 medical schools and their departments, as well as independent hospitals across the United States.
For her work investigating meiotic cell cycle regulation and chromosome segregation in budding yeast and mouse oogenesis, Soni Lacefield, PhD, a professor of biochemistry and cell biology at Dartmouth’s Geisel of Medicine, has received the Genetics Society of America’s Ira Herskowitz Award.
“One of the most important updates we’ve made to the existing Patients and Populations course is a shift to a longitudinal research and health sciences curriculum connecting across all four years of medical school,” says Julie Taylor, MD, MSc, associate dean for medical education, and interim chair of the Department of Community and Family Medicine at Geisel School of Medicine.
Results from a Geisel School of Medicine study investigating whether following a planetary health style diet during pregnancy affects preterm birth and babies’ size at birth are published in the American Journal of Clinical Nutrition, “Adherence to the EAT-Lancet Planetary Health Diet during Pregnancy and Associations with Preterm Birth and Infant Size: a prospective analysis from the New Hampshire Birth Cohort.”
The Geisel School of Medicine’s Office of Diversity, Inclusion, and Community Engagement (DICE) has been awarded a one-year grant to support the Alliance for Scholarship, Collaboration, Engagement, Networking, and Development (ASCEND), from Genentech, a member of the Roche Group, a pioneer in scientific breakthroughs dedicated to improving people’s lives.
January’s Medical Student Grand Rounds at DHMC, featured four Geisel School of Medicine students who shared a systematic review to determine whether hyperosmolar therapy targeting a specific serum sodium level improves neurological outcomes, examined whether elevated FGF23 is associated with changes in bone structure and function following kidney injury, and tested parameters of nanoscale architecture leading to the development of antifibrotic glaucoma drainage implants to reduce post operative fibrosis.
As generative AI rapidly transforms healthcare delivery and medical education, faculty need practical skills to guide students in using these new tools responsibly.
Divya Kaushal, MS MPH’26, alongside Julie Taylor, MD, MSc, associate dean for medical education, interim chair of community and family medicine and professor of medical education, Frances Lim-Liberty, MD, assistant professor of pediatrics and of medical education, and Deborah Hoffer, MD, assistant professor of pediatrics and of medical education, presented Geisel’s innovative longitudinal curriculum threads in Child Development, Health and Illness, Nutrition, and Health Equity at the Bright Start International Conference in London, England. The conference convened educators, early-childhood specialists, physicians, researchers and policymakers from around the world, fostering a dynamic atmosphere for interdisciplinary learning and collaboration.
A team of researchers, led by Lisa Marsch, PhD, at Dartmouth’s Geisel School of Medicine, has received a four-year $13-million grant from the National Institute on Drug Abuse (NIDA) to conduct the first-ever multisite clinical trial evaluating long-acting medication in the treatment of opioid use disorder among adolescents.
This page may link to PDF files. Use this link to download Adobe Reader if needed.